Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1 - PubMed (original) (raw)
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1
P Tan et al. J Exp Med. 1993.
Abstract
The specificity of T lymphocyte activation is determined by engagement of the T cell receptor (TCR) by peptide/major histocompatibility complexes expressed on the antigen-presenting cell (APC). Lacking costimulation by accessory molecules on the APC, T cell proliferation does not occur and unresponsiveness to subsequent antigenic stimulus is induced. The B7/BB1 receptor on APCs binds CD28 and CTLA-4 on T cells, and provides a costimulus for T cell proliferation. Here, we show that prolonged, specific T cell hyporesponsiveness to antigenic restimulation is achieved by blocking the interaction between CD28 and B7/BB1 in human mixed leukocyte culture (MLC). Secondary T cell proliferative responses to specific alloantigen were inhibited by addition to the primary culture of monovalent Fab fragments of anti-CD28 monoclonal antibody (mAb) 9.3, which block interaction of CD28 with B7/BB1 without activating T cells. Hypo-responsiveness was also induced in MLC by CTLA4Ig, a chimeric immunoglobulin fusion protein incorporating the extracellular domain of CTLA-4 with high binding avidity for B7/BB1. Cells previously primed could also be made hyporesponsive, if exposed to alloantigen in the presence of CTLA4Ig. Maximal hyporesponsiveness was achieved in MLC after 2 d of incubation with CTLA4Ig, and was maintained for at least 27 d after removal of CTLA4Ig. Accumulation of interleukin 2 (IL-2) and interferon gamma but not IL-4 mRNA was blocked by CTLA4Ig in T cells stimulated by alloantigen. Antigen-specific responses could be restored by addition of exogenous IL-2 at the time of the secondary stimulation. Addition to primary cultures of the intact bivalent anti-CD28 mAb 9.3, or B7/BB1+ transfected CHO cells or exogenous IL-2, abrogated induction of hyporesponsiveness by CTLA4Ig. These data indicate that interaction of CD28 with B7/BB1 during TCR engagement with antigen is required to maintain T cell competence and that blocking such interaction can result in a state of T cell hyporesponsiveness.
Similar articles
- The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
Koulova L, Clark EA, Shu G, Dupont B. Koulova L, et al. J Exp Med. 1991 Mar 1;173(3):759-62. doi: 10.1084/jem.173.3.759. J Exp Med. 1991. PMID: 1847724 Free PMC article. - Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P. Woodward JE, et al. Transplantation. 1996 Oct 15;62(7):1011-8. doi: 10.1097/00007890-199610150-00021. Transplantation. 1996. PMID: 8878397 - B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes.
Tan R, Teh SJ, Ledbetter JA, Linsley PS, Teh HS. Tan R, et al. J Immunol. 1992 Nov 15;149(10):3217-24. J Immunol. 1992. PMID: 1385518 - Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
Schwartz RH. Schwartz RH. Cell. 1992 Dec 24;71(7):1065-8. doi: 10.1016/s0092-8674(05)80055-8. Cell. 1992. PMID: 1335362 Review. No abstract available. - Costimulation and its role in organ transplantation.
Bluestone JA. Bluestone JA. Clin Transplant. 1996 Feb;10(1 Pt 2):104-9. Clin Transplant. 1996. PMID: 8680045 Review.
Cited by
- Uric acid enhances T cell immune responses to hepatitis B surface antigen-pulsed-dendritic cells in mice.
Ma XJ, Tian DY, Xu D, Yang DF, Zhu HF, Liang ZH, Zhang ZG. Ma XJ, et al. World J Gastroenterol. 2007 Feb 21;13(7):1060-6. doi: 10.3748/wjg.v13.i7.1060. World J Gastroenterol. 2007. PMID: 17373740 Free PMC article. - Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.
Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, Hochberg MC, Qi K, Suissa S. Simon TA, et al. Ann Rheum Dis. 2009 Dec;68(12):1819-26. doi: 10.1136/ard.2008.097527. Epub 2008 Dec 3. Ann Rheum Dis. 2009. PMID: 19054822 Free PMC article. - Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.
Manikwar P, Kiptoo P, Badawi AH, Büyüktimkin B, Siahaan TJ. Manikwar P, et al. Med Res Rev. 2012 Jul;32(4):727-64. doi: 10.1002/med.20243. Epub 2011 Mar 23. Med Res Rev. 2012. PMID: 21433035 Free PMC article. Review. - Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.
Gause WC, Urban JF, Linsley P, Lu P. Gause WC, et al. Immunol Res. 1995;14(3):176-88. doi: 10.1007/BF02918215. Immunol Res. 1995. PMID: 8778208 Review. - Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.
Lu L, McCaslin D, Starzl TE, Thomson AW. Lu L, et al. Transplantation. 1995 Dec 27;60(12):1539-45. doi: 10.1097/00007890-199560120-00028. Transplantation. 1995. PMID: 8545887 Free PMC article.
References
- J Immunol. 1987 Jun 1;138(11):3704-12 - PubMed
- J Exp Med. 1987 Feb 1;165(2):302-19 - PubMed
- Proc Natl Acad Sci U S A. 1986 Aug;83(16):5894-8 - PubMed
- J Exp Med. 1986 Apr 1;163(4):1018-23 - PubMed
- J Immunol. 1986 Mar 15;136(6):2095-102 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous